HIV/AIDS Clinical Trials in New York

Showing 221-240 of 674 trials

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

NCT00107549

The purpose of this study is to determine the safety of two recombinant HIV vaccines in HIV infected young adults on stable anti-HIV therapy.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)20 participants

Los Angeles, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +6 more locations

COMPLETEDPhase 1< 1 mile

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

NCT00660972

The HIV integrase inhibitor, raltegravir (RAL), which was recently approved by the FDA, has been shown in several trials to be highly effective. The purpose of this trial is to estimate the viral load decay rate in treatment-naive HIV infected participants receiving RAL and emtricitabine/tenofovir disoproxil fumarate (FTC/TDF).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted May 2008

San Diego, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +12 more locations

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

HIV/AIDS Trials in Other Cities

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Other Conditions in New York